Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 7/20 | 0.38 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | AHR | P35869 | 2/20 | 0.38 |
| ▸ | PAX8 | Q06710 | 2/20 | 0.38 |
| ▸ | FYN | P06241 | 1/20 | 0.38 |
| ▸ | MAPK3 | P27361 | 1/20 | 0.38 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.32 |
| ▸ | PRKDC | P78527 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ANO1 | Q5XXA6 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24048098 | 0.96 | ABCG2 (0.39) | ABCG2CYP1A1CYP1A2AHRPAX8 | |
| SCHEMBL24048436 | 0.96 | ABCG2 (0.40) | ABCG2CYP1A1CYP1A2AHRPAX8 | |
| SCHEMBL24048424 | 0.96 | ABCG2 (0.40) | ABCG2CYP1A1CYP1A2AHRPAX8 | |
| SCHEMBL24152925 | 0.94 | ABCG2 (0.38) | ABCG2CYP1A1CYP1A2AHRPAX8 | |
| SCHEMBL24152931 | 0.94 | ABCG2 (0.34) | ABCG2CYP1A1CYP1A2AHRPAX8 | |
| SCHEMBL24152927 | 0.93 | ABCG2 (0.39) | ABCG2CYP1A1CYP1A2AHRPAX8 | |
| SCHEMBL24048473 | 0.93 | ABCG2 (0.36) | ABCG2CYP1A1CYP1A2AHRPAX8 | |
| SCHEMBL24047938 | 0.91 | ABCG2 (0.42) | ABCG2CYP1A1CYP1A2AHRPAX8 | |
| SCHEMBL24152077 | 0.91 | ABCG2 (0.42) | ABCG2CYP1A1CYP1A2AHRPAX8 | |
| SCHEMBL24047373 | 0.88 | ABCG2 (0.37) | ABCG2CYP1A1CYP1A2AHRPAX8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230337531-A1 | NOVEL COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | LG CHEM, LTD. (KR) | 2023-10-19 | — | — | US | disclosed |
| US-20230337531-A1 | NOVEL COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | LG CHEM, LTD. (KR) | 2023-10-19 | — | — | US | disclosed |
| WO-2023003436-A1 | ORGANIC LIGHT-EMITTING DEVICE | 주식회사 엘지화학 | 2023-01-26 | — | — | WO | disclosed |
| WO-2021261977-A1 | ORGANIC LIGHT-EMITTING DEVICE | 주식회사 엘지화학 | 2021-12-30 | — | — | WO | disclosed |
| WO-2021235830-A1 | NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | 주식회사 엘지화학 | 2021-11-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230337531-A1 | NOVEL COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | CRY1, AHR, CRY2 | ABCG2 2570/4885CYP1A1 21/4885CYP1A2 127/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.